MarketPeel
Insider Trading Intelligence
BS

Brian M. Stolz

BBIO
CHIEF OPERATING OFFICER · BRIDGEBIO PHARMA, INC. · CIK 0001524803
FILING MIX · LIFETIME60%/40%
BUYS
3
SELLS
2
TOTAL VALUE
$15.7K
COMPANIES
1
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
23,937
AVG SELL PX
$28.53
TRADE KIND
SHOWING 5 / 5
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Brian M. Stolz. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
BBIO · 23,937 shares · as of Aug 16, 2020
045,93291,864137,795183,727SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
FLOW · 3 buys / 2 sellsCOVERAGE · 2 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASE
Chief Operating Officer
1,59525,167Aug 16, 2020Aug 18, 2020
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Operating Officer
552$28.53$15.7K24,615Aug 16, 2020Aug 18, 2020
BBIO
BRIDGEBIO PHARMA, INC.
SALE
Chief Operating Officer
1,59523,937Aug 16, 2020Aug 18, 2020
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASEGRANT
Stock grant
25,53225,532Jun 3, 2020Jun 5, 2020
BBIO
BRIDGEBIO PHARMA, INC.
PURCHASEGRANT
Stock grant
183,727183,727Jun 3, 2020Jun 5, 2020
Other insiders · BBIO
Loading peer insiders…
About this filer
CIK 0001524803
ROLE
Chief Operating Officer
PRIMARY
BBIO
COMPANIES
1
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001524803DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback